Portfolio

Regulatory Codification of Coverage-Medicare Advantage Plansadmin2023-05-02T09:20:57-07:00

Women’s Business Enterprise National Council (WBENC) Re-Certifies Rowinski Group as a Women Business Enterprise (WBE)admin2023-04-14T10:29:11-07:00

Public Comment for the CMS Proposed Medicare Payment rates for the Hospital Outpatient and Ambulatory Surgical Centeradmin2022-10-11T07:16:42-07:00

FDA Designated Breakthrough Devices-Upcoming Proposal to Expedite Medicare Coverageadmin2022-05-31T17:10:28-07:00

Rowinski Group Awarded National Re-Certification as a Women’s Business Enterpriseadmin2022-02-22T04:11:34-08:00

The University of California-San Francisco (UCSF) Rosenman Institute Program Funding OpportunitySusan Rowinski2021-03-26T14:51:58-07:00

Rowinski Group Awarded National Re-Certification by the Women’s Business Enterprise National CouncilSusan Rowinski2021-03-26T16:10:06-07:00

Permanent Changes to Medicare Reimbursement for Cliniciansadmin2021-03-26T14:52:43-07:00

University Licensing Dept Wants to Improve Corporate Transactions, Listens to Payers for Adviceadmin2021-03-31T13:37:25-07:00

Diagnostic Company Uses Reimbursement Data for Regulatory and FDA Planningadmin2021-03-31T13:33:35-07:00